Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Key takeaways: Compounded glucagon-like peptide-1 (GLP-1) medications gained popularity during shortages of FDA-approved brand-name GLP-1s
With the increased use of drugs for ADHD globally, the benefits of methylphenidate should be carefully weighed against the potential cardiovascular risks of these drugs in children and adolescents, they added
Guidelines for use in obesity Semaglutide is recommended as an option for weight management, including weight loss and weight maintenance, alongside a reduced-calorie diet and increased physical activity in adults, only if: it is used for a maximum of 2 years, and within a specialist weight management service providing multidisciplinary management of overweight or obesity (including but not limited to tiers 3 and 4), and they have at least 1 weight-related comorbidity and : a body mass index (BMI) of at least 35.0 kg/m2, or a BMI of 30.0 kg/m2 to 34.9 kg/m2 and meet the criteria for referral to specialist weight management services in NICEs guideline on obesity: identification, assessment and management
Many semaglutide medications like Ozempic and Rybelsus are still only approved for treating type-2 diabetes, but drug companies have rushed to create weight loss-specific versions to capitalize on the craze
